Bioline HIV/Syphilis Duo
ApprovedImmunochromatographic (lateral flow) rapid test that detects HIV and syphilis together; WHO prequalified in 2015.
Abbott's Korean subsidiary in Giheung-gu, Yongin, Gyeonggi-do, which manufactures and exports in vitro diagnostic devices such as Bioline rapid tests for HIV, hepatitis and malaria.
Immunochromatographic (lateral flow) rapid test that detects HIV and syphilis together; WHO prequalified in 2015.
Family of immunochromatographic rapid tests detecting malaria antigens; several variants were WHO prequalified between 2010 and 2018.
Rapid tests for hepatitis C (HCV) and hepatitis B surface antigen (HBsAg), formerly sold under the SD BIOLINE name; WHO prequalified in 2016 and 2017 respectively.
Head office and production base at 65 Borahagal-ro, Giheung-gu, Yongin, Gyeonggi-do. In 2021 its in vitro diagnostic device production was KRW 606.4 billion and exports were USD 553.99 million.
Official role guide
Observed 2026-10-26
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.